Gilteritinib prolongs survival in patients with FLT3-mutated relapsed/refractory acute myeloid leukaemia who have common AML comutations or a high FLT3-internal tandem duplication allelic ratio Meeting Abstract


Authors: Levis, M. J.; Perl, A. E.; Martinelli, G.; Cortes, J. E.; Neubauer, A.; Berman, E.; Montesinos, P.; Baer, M. R.; Larson, R. A.; Chou, W. C.; Yokoyama, H.; Recher, C.; Yoon, S. S.; Hill, J. E.; Rosales, M.; Liu, C.; Bahceci, E.
Abstract Title: Gilteritinib prolongs survival in patients with FLT3-mutated relapsed/refractory acute myeloid leukaemia who have common AML comutations or a high FLT3-internal tandem duplication allelic ratio
Meeting Title: 60th Annual Scientific Meeting of the British Society for Haematology (BSH)
Journal Title: British Journal of Haematology
Volume: 189
Issue: Suppl. 1
Meeting Dates: 2020 Apr 27-29
Meeting Location: Birmingham, UK
ISSN: 0007-1048
Publisher: John Wiley & Sons  
Date Published: 2020-04-01
Start Page: 7
End Page: 8
Language: English
ACCESSION: WOS:000528597400007
PROVIDER: wos
PUBMED: 32337705
DOI: 10.1111/bjh.16638
Notes: Meeting cancelled due to COVID-19 pandemic -- Meeting Abstract: BSH2020-OR-005 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Ellin Berman
    173 Berman